DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 107 filers reported holding DEPOMED INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,919,000 | -37.5% | 238,395 | -55.0% | 0.01% | -45.5% |
| Q3 2017 | $3,070,000 | +383.5% | 530,245 | +796.7% | 0.01% | +450.0% |
| Q2 2017 | $635,000 | -68.5% | 59,136 | -63.2% | 0.00% | -71.4% |
| Q1 2017 | $2,016,000 | -9.7% | 160,653 | +0.3% | 0.01% | -36.4% |
| Q1 2016 | $2,232,000 | -67.8% | 160,201 | -58.1% | 0.01% | -66.7% |
| Q4 2015 | $6,927,000 | +538.4% | 382,057 | +563.7% | 0.03% | +450.0% |
| Q3 2015 | $1,085,000 | -64.8% | 57,563 | -60.0% | 0.01% | -57.1% |
| Q2 2015 | $3,084,000 | -80.7% | 143,731 | -79.8% | 0.01% | -82.3% |
| Q1 2015 | $15,985,000 | +225.5% | 713,300 | +134.0% | 0.08% | +192.6% |
| Q4 2014 | $4,911,000 | +7.2% | 304,813 | +1.0% | 0.03% | +35.0% |
| Q3 2014 | $4,583,000 | +49.3% | 301,741 | +42.5% | 0.02% | +25.0% |
| Q1 2014 | $3,070,000 | -3.8% | 211,738 | -29.8% | 0.02% | -11.1% |
| Q4 2013 | $3,192,000 | +505.7% | 301,708 | +327.8% | 0.02% | +500.0% |
| Q3 2013 | $527,000 | – | 70,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |